Growth Metrics

Vycor Medical (VYCO) Depreciation & Amortization (CF) (2016 - 2025)

Vycor Medical has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $16144.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 4.3% to $16144.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63143.0 through Dec 2025, down 1.2% year-over-year, with the annual reading at $63143.0 for FY2025, 1.2% down from the prior year.
  • Depreciation & Amortization (CF) was $16144.0 for Q4 2025 at Vycor Medical, up from $15868.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $16869.0 in Q4 2024 and troughed at $11162.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $15401.0 (2021), against an average of $15313.8.
  • Year-over-year, Depreciation & Amortization (CF) skyrocketed 54.36% in 2021 and then decreased 4.3% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $15404.0 in 2021, then fell by 0.48% to $15330.0 in 2022, then fell by 1.49% to $15102.0 in 2023, then rose by 11.7% to $16869.0 in 2024, then dropped by 4.3% to $16144.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Depreciation & Amortization (CF) are $16144.0 (Q4 2025), $15868.0 (Q3 2025), and $15021.0 (Q2 2025).